| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) (NCT04883658) | Chong Kun Dang Pharmaceutical | 2021-06-04 |
| Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions (NCT04906798) | Chong Kun Dang Pharmaceutical | 2021-06-04 |
| A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations. (NCT04903093) | Pfizer | 2021-06-04 |
| SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers (NCT04808414) | Qpex Biopharma, Inc. | 2021-06-03 |
| A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations (NCT06132932) | Shanghai Jiatan Pharmatech Co., Ltd | 2021-06-03 |
| PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment (NCT04849650) | Acacia Pharma Ltd | 2021-06-03 |
| Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE (NCT04643067) | Kangpu Biopharmaceuticals, Ltd. | 2021-06-03 |
| Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers (NCT04868292) | Spero Therapeutics | 2021-06-03 |
| Ultra-fractionated Radiotherapy for Rectal Cancer (NCT04677413) | University of Texas Southwestern Medical Center | 2021-06-03 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
| Image - Navigated Resection of Lung Nodules (NCT04702165) | Navigation Sciences, Inc. | 2021-06-03 |
| Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma (NCT04892264) | Mayo Clinic | 2021-06-03 |
| A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 (NCT05086666) | Abbisko Therapeutics Co, Ltd | 2021-06-03 |
| Bioequivalence Study of Esomeprazole in Healthy Adult Subjects Under Fasting Condition (NCT05235217) | Future University in Egypt | 2021-06-03 |
| Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months (NCT04909021) | Meissa Vaccines, Inc. | 2021-06-03 |
| Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD (NCT04884399) | Shanghai Biomabs Pharmaceutical Co., Ltd. | 2021-06-03 |
| The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. (NCT06160440) | Guangzhou JOYO Pharma Co., Ltd | 2021-06-03 |
| Irritation and Sensitization Study of HP-5000 Topical System (NCT04882319) | Noven Pharmaceuticals, Inc. | 2021-06-03 |
| Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects (NCT04909723) | Novome Biotechnologies Inc | 2021-06-02 |
| Clinical Efficiency of Xanthan Hydrogels Containing Local Anesthetics Encapsulated in Nanostructured Lipid Carries (NCT05912335) | University of Campinas, Brazil | 2021-06-02 |
| A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer (NCT05337657) | Genor Biopharma Co., Ltd. | 2021-06-02 |
| Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study (NCT04917731) | Massachusetts General Hospital | 2021-06-02 |
| Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas (NCT04730583) | Massachusetts General Hospital | 2021-06-02 |
| Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn (NCT04898114) | Sohag University | 2021-06-02 |
| Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease (NCT04759365) | Asceneuron Pty Ltd. | 2021-06-02 |
| Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers (NCT05938517) | Ludwig-Maximilians - University of Munich | 2021-06-02 |
| Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy (NCT04950504) | COUR Pharmaceutical Development Company, Inc. | 2021-06-02 |
| A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants (NCT04840901) | Eli Lilly and Company | 2021-06-02 |
| A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies (NCT04954456) | Qilu Pharmaceutical Co., Ltd. | 2021-06-02 |
| PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI (NCT05172310) | Karolinska University Hospital | 2021-06-02 |
| Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer (NCT04835896) | Yonsei University | 2021-06-02 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants (NCT04878471) | Astellas Pharma Inc | 2021-06-02 |
| Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients (NCT05447013) | George Papanicolaou Hospital | 2021-06-02 |
| A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy (NCT04873752) | Rohto Pharmaceutical Co., Ltd. | 2021-06-02 |
| CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma (NCT05054257) | Institute of Hematology and Blood Transfusion, Czech Republic | 2021-06-02 |
| Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval (NCT04898907) | Angion Biomedica Corp | 2021-06-01 |
| Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies (NCT05362513) | Combined Military Hospital Abbottabad | 2021-06-01 |
| Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer (NCT04840758) | The First Affiliated Hospital of Xiamen University | 2021-06-01 |
| Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis (NCT04478825) | Bridge Biotherapeutics, Inc. | 2021-06-01 |
| A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma (NCT05022927) | Chugai Pharmaceutical | 2021-06-01 |
| Closed-loop Optimized rTMS for Depression (NCT04142320) | Stanford University | 2021-06-01 |
| AB122 Platform Study (NCT04999761) | Taiho Pharmaceutical Co., Ltd. | 2021-06-01 |
| Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse (NCT04195776) | Johns Hopkins University | 2021-06-01 |
| Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) (NCT04922047) | RenJi Hospital | 2021-06-01 |
| Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors (NCT04856774) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-06-01 |
| Study of AlloGen® Liquid Intra-articular Injection for Knee Osteoarthritis (NCT04835389) | VIVEX Biologics, Inc. | 2021-06-01 |
| Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD (NCT04907526) | Timothy J Nelson, MD, PhD | 2021-06-01 |
| Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis (NCT04833764) | Khanh Nguyen | 2021-06-01 |
| Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa (NCT04925687) | University of California, Davis | 2021-06-01 |
| Nanofat Versus Platelet Poor Plasma Gel for Infraorbital Rejuvenation (NCT06318091) | Mansoura University | 2021-06-01 |
| Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma (NCT04855136) | Celgene | 2021-06-01 |
| Nitrite Infusion in Children With Malaria (NCT04289558) | Duke University | 2021-06-01 |
| A Phase I/II Study to Investigate the Use of VORAXAZE™ As Intended Intervention in Patients with CNSL (NCT04841434) | Charite University, Berlin, Germany | 2021-06-01 |
| Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects (NCT04920786) | TrueBinding, Inc. | 2021-06-01 |
| A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects (NCT04818229) | Connect Biopharma Australia Pty Ltd | 2021-06-01 |
| Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer (NCT04929652) | Jiangsu Cancer Institute & Hospital | 2021-06-01 |
| An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer (NCT06542731) | Ono Pharmaceutical Co., Ltd. | 2021-06-01 |
| Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer (NCT04906044) | The First Hospital of Jilin University | 2021-06-01 |
| A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction (NCT04840914) | Eli Lilly and Company | 2021-06-01 |
| A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants (NCT04903821) | Bayer | 2021-06-01 |
| Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer (NCT04926753) | Ruijin Hospital | 2021-06-01 |
| Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia (NCT04762485) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| A Clinical Trial of TAA06 Injection in Advanced Solid Tumors (NCT05190185) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-06-01 |
| Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440 (NCT03890341) | Janssen Research & Development, LLC | 2021-06-01 |
| Abatacept s.c. for aGVHD Prevention in Haplo-HCT (NCT04686929) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's (NCT04073472) | The Cleveland Clinic | 2021-06-01 |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors (NCT04616534) | National Cancer Institute (NCI) | 2021-06-01 |
| Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis (NCT04863183) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2021-06-01 |
| First in Human Study of ORG-129 in Healthy Volunteers (NCT04933565) | Origo Biopharma | 2021-06-01 |
| Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC (NCT04951063) | Sun Yat-sen University | 2021-06-01 |
| Enriched Heparin Anti COVID-19 Trial (NCT04743011) | UPECLIN HC FM Botucatu Unesp | 2021-06-01 |
| Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma (NCT05362500) | Combined Military Hospital Abbottabad | 2021-06-01 |
| Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention (NCT05032781) | Northwell Health | 2021-06-01 |
| Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19 (NCT04801056) | TrueBinding, Inc. | 2021-06-01 |
| Food or Supplemental Lutein Absorption (NCT04786392) | The University of Queensland | 2021-06-01 |
| A Clinical Trial of Chidamide in the Management of Refractory ITP (NCT03838354) | Shandong University | 2021-06-01 |
| Microtransplantation for Advanced and Relapsed Solid Tumors (NCT04937842) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2021-06-01 |
| Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction (NCT06544447) | Beijing Tongren Hospital | 2021-06-01 |
| PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing (NCT04787302) | Cerevel Therapeutics, LLC | 2021-06-01 |
| Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers (NCT04802174) | National Cancer Institute (NCI) | 2021-06-01 |
| Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD (NCT05140616) | The First Affiliated Hospital of Soochow University | 2021-05-31 |
| A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors (NCT04903873) | Eutilex | 2021-05-31 |
| The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects (NCT04880512) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-05-31 |
| A Study to Evaluate the Similarity in Pharmacokinetics and Safety of IBI310 and Ipilimumab（YERVOY）in Adult Healthy Chinese Male Volunteers (NCT04868760) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-05-31 |
| A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects (NCT04913090) | Xuanzhu Biopharmaceutical Co., Ltd. | 2021-05-31 |
| A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS (NCT04852419) | Zentera Therapeutics HK Limited | 2021-05-31 |
| Cultivating Resilience in Oncology Practice (NCT04902313) | Linkoeping University | 2021-05-31 |
| Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers (NCT04885829) | Syneos Health | 2021-05-31 |
| Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets (NCT04868981) | Fujian Cosunter Pharmaceutical Co. Ltd | 2021-05-31 |
| Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance (NCT04728035) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-05-31 |
| APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (NCT04260217) | Ascentage Pharma Group Inc. | 2021-05-30 |
| Safety and Tolerability Study of IV ST266 in COVID-19 Subjects (NCT04720378) | Noveome Biotherapeutics, formerly Stemnion | 2021-05-30 |
| Dysport Dose-Ranging Treatment of Platysmal Bands (NCT04886167) | Clinical Testing of Beverly Hills | 2021-05-30 |
| A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants (NCT04712006) | Janssen Research & Development, LLC | 2021-05-30 |
| Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers (NCT05470764) | Darnitsa Pharmaceutical Company | 2021-05-30 |
| Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants (NCT04958135) | Alexion Pharmaceuticals, Inc. | 2021-05-30 |
| Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia (NCT04581785) | LogicBio Therapeutics, Inc | 2021-05-29 |
| Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC) (NCT04658147) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-05-28 |
| Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects (NCT04927793) | Enanta Pharmaceuticals, Inc | 2021-05-28 |
| Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC (NCT04629781) | Swiss Cancer Institute | 2021-05-28 |